Your browser doesn't support javascript.
loading
Cardiovascular Toxicities of Immune Checkpoint Inhibitors: JACC Review Topic of the Week.
Ball, Somedeb; Ghosh, Raktim K; Wongsaengsak, Sariya; Bandyopadhyay, Dhrubajyoti; Ghosh, Gopal Chandra; Aronow, Wilbert S; Fonarow, Gregg C; Lenihan, Daniel J; Bhatt, Deepak L.
Afiliación
  • Ball S; Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas.
  • Ghosh RK; Department of Cardiology, Case Western Reserve University, Heart and Vascular Institute, MetroHealth Medical Center, Cleveland, Ohio.
  • Wongsaengsak S; Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas.
  • Bandyopadhyay D; Department of Internal Medicine, Icahn School of Medicine at Mount Sinai/Mount Sinai St. Luke's Roosevelt Hospital, New York, New York.
  • Ghosh GC; Department of Cardiology, Apollo Gleneagles Hospital, Kolkata, India.
  • Aronow WS; Division of Cardiology, Westchester Medical Center and New York Medical College, Valhalla, New York.
  • Fonarow GC; Division of Cardiovascular Medicine, University of California-Los Angeles, Los Angeles, California.
  • Lenihan DJ; Cardio-Oncology Center of Excellence, Division of Cardiology, Washington University in St. Louis, St. Louis, Missouri.
  • Bhatt DL; Brigham and Women's Hospital Heart & Vascular Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts. Electronic address: dlbhattmd@post.harvard.edu.
J Am Coll Cardiol ; 74(13): 1714-1727, 2019 10 01.
Article en En | MEDLINE | ID: mdl-31558256

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Cardiología / Enfermedades Cardiovasculares / Cardiotoxinas / Antineoplásicos Inmunológicos / Factores Inmunológicos Tipo de estudio: Clinical_trials / Guideline País/Región como asunto: America do norte Idioma: En Revista: J Am Coll Cardiol Año: 2019 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Cardiología / Enfermedades Cardiovasculares / Cardiotoxinas / Antineoplásicos Inmunológicos / Factores Inmunológicos Tipo de estudio: Clinical_trials / Guideline País/Región como asunto: America do norte Idioma: En Revista: J Am Coll Cardiol Año: 2019 Tipo del documento: Article